Clinical trial
ADMA Levels in End-Stage Renal Disease
NCT00350974 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00350974 |
|---|---|
| Title | ADMA Levels in End-Stage Renal Disease |
| Official title | Determination of Asymmetrical Dimethylarginine (ADMA) Accumulation in End Stage Renal Disease |
| Lead sponsor | University of Michigan, Other |
| Collaborators | Renal Research Institute |
| Status | Completed |
| Study type | Observational |
| Conditions | Chronic Kidney Disease, Hypertension |
| Enrollment | 61 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 8, 2007 |
| Completion | Mar 8, 2007 |
| First posted | Jul 11, 2006 |
| Last update posted | Jun 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: